← All indications
Hyperkinesis
Excessive movement of muscles of the body as a whole, which may be associated with organic or psychological disorders.
Drugs by status
Organizations
Organization Involved with Phase 4 Indications (101)
- Arbor Pharmaceuticals
- McNeil
- Shire
- Bristol-Myers Squibb
- Eli Lilly
- Pfizer
- Shionogi
- Purdue Pharmaceuticals
- Novartis
- BRC Operations Pty. Ltd.
- Laboratorios Ordesa
- Lallemand SAS
- Noven Therapeutics
- Rhodes Pharmaceuticals, L.P.
- Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
- National Institutes of Health (NIH)
- National Institute of Mental Health (NIMH)
- National Institute on Drug Abuse (NIDA)
- Douglas Sears
- UMC Utrecht
- Region Syddanmark
- University of Pennsylvania
- Acadia University
- University of Arizona
- University of Pittsburgh
- Boston Urogynecology Associates
- Brown University
- Case Western Reserve University
- Children's Specialized Hospital
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- +71 more
Organization Involved with Phase 3 Indications (46)
- New River Pharmaceuticals
- Spectrum Pharmaceuticals
- Cephalon
- Pamlab
- Sanofi
- Alza
- Alcobra Ltd.
- GlaxoSmithKline
- Ironshore Pharmaceuticals and Development, Inc
- Medice Arzneimittel Pütter GmbH & Co KG
- Neos Therapeutics, Inc
- Sunovion
- Tris Pharma, Inc.
- Yuyu Pharma, Inc.
- Otsuka
- ZonMw: The Netherlands Organisation for Health Research and Development
- National Institute of Neurological Disorders and Stroke (NINDS)
- Allameh Tabatabai University
- Inje University
- IRCCS Eugenio Medea
- The Canadian College of Naturopathic Medicine
- University of Oklahoma
- University of Alberta
- Penang Medical College
- Saarland University
- University of California, San Francisco
- University of Utah
- University of Minnesota
- University of Amsterdam
- Semnan University
- +16 more
Organization Involved with Phase 2 Indications (40)
- Abbott
- AbbVie
- Chelsea Therapeutics
- Targacept
- Theravance
- Vernalis
- Merck
- CoMentis
- Aevi Genomic Medicine
- BioLite, Inc.
- Clinical Study Centers, LLC
- Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
- Mensia Technologies SA
- NeuroDerm Ltd.
- NeuroSearch A/S
- Neurovance, Inc.
- NLS Pharma Inc.
- National Center for Complementary and Integrative Health (NCCIH)
- Bastyr University
- Chiba University
- Johns Hopkins University
- Medical University of Warsaw
- University of Santiago de Compostela
- University of British Columbia
- Vanderbilt University
- Medical University of South Carolina
- University of Freiburg
- University of Montpellier
- Isfahan University
- Centre for Psychiatry & Behavioral Medicine, Inc.
- +10 more
Organization Involved with Phase 1 Indications (6)
Organization Involved with Other Experimental Indications (27)
- Unilever
- Korea Research Foundation
- National Institute of Nursing Research (NINR)
- Baylor University
- University of London
- Cox Health Systems
- Florida International University
- Norwegian University of Science and Technology
- Tel Hai College
- University of South Carolina
- University of Virginia
- Taipei Medical University
- University of Ulm
- Food and Drug Administration
- Hebrew University
- pediatric neurology of the ozarks
- Ben Gurion University
- University of Colorado
- South London and Maudsley NHS Foundation Trust
- American Academy of Child Adolescent Psychiatry.
- Samsung
- Sungkyunkwan University
- Israel Association of Pediatricians
- China Medical University
- Government of Singapore
- Xijing Hospital
- Centre Hospitalier Rouffach